Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics
Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics
批准号:
8648134
负责人:
DAOJING WANG
金额:
$34.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2016-04-30
关键词:
AddressBindingBiologicalBiological MarkersBiomedical ResearchBreast Cancer CellCaliberChargeChemistryCollaborationsCouplingDetectionDevelopmentDiagnosticDigestionDiseaseEarly DiagnosisElectrodesElectrospray IonizationHumanIndividualIndustryIonsLengthLiquid ChromatographyMass Spectrum AnalysisMeasuresMicrofluidicsModificationMolecular WeightMonitorPathologyPatientsPeptide HydrolasesPeptidesPerformancePhasePhysiologyPlasmaProtein ChemistryProtein IsoformsProteinsProteomeProteomicsRNA SplicingRelative (related person)ReproducibilityRunningSamplingSensitivity and SpecificityShotgunsSiliconSolutionsSolventsSpectrometry, Mass, Electrospray IonizationTechnologyTherapeuticTrypsinValidationbaseimmunoaffinity chromatographyinnovationionizationliquid chromatography mass spectrometrymass spectrometernew technologynext generationnoveloperationprogramsprotein protein interactionpublic health relevanceresponsesmall moleculesuccesstool
中文摘要
项目总结/摘要
蛋白质组反映了患者的生理和病理状态,因此蛋白质组学是一个强有力的工具
用于疾病的早期诊断和治疗反应的监测。质谱(MS)测量
带电物质的质荷比,并已成为蛋白质组学的使能技术。
然而,目前大多数蛋白质组学研究依赖于自下而上/鸟枪法。在这种情况下,
蛋白质混合物被蛋白酶之一消化(例如,胰蛋白酶),通过液相色谱法分离
(LC)通过电喷雾质谱法(ESI-MS)分析。尽管取得了巨大的成功,
在自下而上的蛋白质组学中仍然存在两个主要限制:首先,很难鉴定所有的蛋白质同种型,
蛋白形式,包括剪接、修饰、裂解等;第二,蛋白质的天然状态总是
消化后消失。目前有一个很大的推动,以实现自上而下的蛋白质组学,即,识别和
通过LC-MS表征全长蛋白质。不幸的是,自上而下的蛋白质组学被证明是更多
挑战性存在几个瓶颈:第一,蛋白质相对于肽的MS灵敏度较低;第二,
限制了高分子量蛋白质的检测;第三,通过MS/MS鉴定蛋白质的效率低
片段化;第四,费力的多维蛋白质分离,不适合小体积的蛋白质分离。
生物样本该领域正在呼唤变革性技术。根据PA-11-215,Newomics
Inc.建议开发一种新技术,皮电喷雾电离质谱(picoESI-MS),
基于我们突破性的多喷嘴发射器阵列,用于小体积样品的自上而下的蛋白质组学。的
技术将建立在我们的微型单片多喷嘴发射器(M3发射器)和多喷嘴
LC-nanoESI-MS发射极阵列(MEA)芯片,共同提供了一种简单而新颖的解决方案,
解决了硅微流控芯片与ESI-MS之间的有效耦合这一长期存在的问题,并为
为LC-picoESI-MS微流控芯片的大规模集成提供了一种新的途径。
平台将直接解决上述瓶颈,从而实现高灵敏度,高通量,
和小体积生物样品的多重自上而下的蛋白质组学。
英文摘要
Project Summary/Abstract
The proteome reflects the physiology and pathology states of a patient therefore proteomics is a powerful tool
for early diagnostics of diseases and monitoring of therapeutic responses. Mass spectrometry (MS) measures
the mass-to-charge ratio of charged species and has become the enabling technology for proteomics.
However, the majority of the current proteomics studies rely on bottom-up/shotgun approaches. In this case,
mixtures of proteins are digested by one of the proteases (e.g., trypsin), separated by liquid chromatography
(LC), and analyzed by electrospray mass spectrometry (ESI-MS). Despite tremendous successes, there
remain two major limitations in bottom-up proteomics: first, it is difficult to identify all protein isoforms or
proteoforms, including splicing, modifications, cleavages, etc.; second, the native state of proteins is always
lost after digestion. There is currently a great push to implement top-down proteomics, i.e., identification and
characterization of full-length proteins by LC-MS. Unfortunately, top-down proteomics proves to be much more
challenging. There are several bottlenecks: first, lower MS sensitivity of protein relative to peptides; second,
limitation on detection of high molecular weight proteins; third, inefficient identification of proteins by MS/MS
fragmentation; and fourth, laborious multidimensional protein separation not suitable for small volumes of
biological samples. The field is calling for transformative technologies. In response to PA-11-215, Newomics
Inc. proposes to develop a new technology, picoelectrospray ionization mass spectrometry (picoESI-MS),
based on our breakthrough multinozzle emitter array, for top-down proteomics of small-volume samples. The
technology will be built on our microfabricated monolithic multinozzle emitters (M3 emitters) and multinozzle
emitter array (MEA) chips for LC-nanoESI-MS, which collectively offer a straightforward yet novel solution to
the longstanding problem of the efficient coupling between silicon microfluidic chips and ESI-MS, and pave the
way for the large-scale integration on the proposed microfluidic chips for LC-picoESI-MS. Our picoESI-MS
platform will directly address the aforementioned bottlenecks and thus enable high-sensitivity, high-throughput,
and multiplex top-down proteomics of small volumes of biological samples.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Senescence-Chips for Radiation Biodosimetry
-
批准号:8646099
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
Ultrahigh-throughput Identification of Molecular Targets of Natural Products
-
批准号:8712293
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease
-
批准号:8779649
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
Senescence-Chips for Radiation Biodosimetry
-
批准号:9901427
-
项目类别:
-
资助金额:$99.74万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
Ultrahigh-throughput Identification of Molecular Targets of Natural Products
-
批准号:9263893
-
项目类别:
-
资助金额:$81.13万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics
-
批准号:10693274
-
项目类别:
-
资助金额:$86.54万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
Picoelectrospray Ionization Mass Spectrometry for Top-down Proteomics
-
批准号:10546686
-
项目类别:
-
资助金额:$86.54万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease
-
批准号:9789132
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
Senescence-Chips for Radiation Biodosimetry
-
批准号:8903697
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
AD-MS Chips for Biofluids-Based Diagnosis of Alzheimer's Disease
-
批准号:8897940
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2014
-
负责人:DAOJING WANG
-
依托单位:
Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells
-
批准号:9488714
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2013
-
负责人:DAOJING WANG
-
依托单位:
Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells
-
批准号:8619939
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2013
-
负责人:DAOJING WANG
-
依托单位:
IGF::OT::IGF OMICS-CHIPS FOR CTC ISOLATION AND MOLECULAR ANALYSIS
-
批准号:8738153
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2013
-
负责人:DAOJING WANG
-
依托单位:
Omics-Based Assays for Screening Chemical Toxicity Using Stem Cells
-
批准号:9207463
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2013
-
负责人:DAOJING WANG
-
依托单位:
Microfluidic Chips for Biomonitoring
-
批准号:8913401
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2012
-
负责人:DAOJING WANG
-
依托单位:
Microfluidic Chips for Biomonitoring
-
批准号:9034579
-
项目类别:
-
资助金额:$74.65万
-
财政年份:2012
-
负责人:DAOJING WANG
-
依托单位:
NanoArrays in Mass Spectrometry for Proteomic and Metabolomic Applications
-
批准号:7230294
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2006
-
负责人:DAOJING WANG
-
依托单位:
NanoArrays in Mass Spectrometry for Proteomic and Metabolomic Applications
-
批准号:7418972
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2006
-
负责人:DAOJING WANG
-
依托单位:
NanoArrays in Mass Spectrometry for Proteomic and Metabolomic Applications
-
批准号:7115425
-
项目类别:
-
资助金额:$20.87万
-
财政年份:2006
-
负责人:DAOJING WANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: